In prostate cancer, the overexpression of aldo-keto reductase 1C3 (AKR1C3), an enzyme involved in PG metabolism, resulted in the accumulation of PGF2α, which not only promotes prostate cancer cell proliferation but also enhances prostate cancer cell resistance to radiation 54. The gene discussed is AKR1C3; the disease is prostate carcinoma.